Breath Insights: Advancing Lung Cancer Early-Stage Detection Through AI Algorithms in Non-Invasive VOC Profiling Trials
Author:
Raimundo Bernardo S.1ORCID, Leitão Pedro M.2ORCID, Vinhas Manuel2ORCID, Pires Maria V.1ORCID, Quintas Laura B.1ORCID, Carvalheiro Catarina1, Barata Rita1, Ip Joana3ORCID, Coelho Ricardo1, Granadeiro Sofia1, Simões Tânia S.1, Gonçalves João1ORCID, Baião Renato1, Rocha Carla1, Alves Sandra4, Fidalgo Paulo5ORCID, Araújo Alípio5ORCID, Matos Cláudia1, Simões Susana1, Alves Paula6, Garrido Patrícia1, Pantarotto Marcos1ORCID, Carreiro Luís1, Matos Rogério1, Bárbara Cristina6ORCID, Cruz Jorge1, Gil Nuno1ORCID, Luis-Ferreira Fernando2ORCID, Vaz Pedro D.1ORCID
Affiliation:
1. Unidade de Pulmão, Centro Clínico Champalimaud, Fundação Champalimaud, 1400-038 Lisboa, Portugal 2. Departamento de Engenharia Electrotécnica e de Computadores, Faculdade de Ciências e Tecnologia, Universidade Nova de Lisboa, Quinta da Torre, 2829-516 Caparica, Portugal 3. Serviço de Radiologia, Centro Clínico Champalimaud, Fundação Champalimaud, 1400-038 Lisboa, Portugal 4. Unidade de Ensaios Clínicos, Centro Clínico Champalimaud, Fundação Champalimaud, 1400-038 Lisboa, Portugal 5. Unidade de Risco e Diagnóstico Precoce, Centro Clínico Champalimaud, Fundação Champalimaud, 1400-038 Lisboa, Portugal 6. Serviço de Pneumologia, Centro Hospitalar e Universitário Lisboa Norte, 1649-035 Lisboa, Portugal
Abstract
Background: Lung cancer (LC) is the leading cause of cancer-related deaths worldwide. Effective screening strategies for early diagnosis that could improve disease prognosis are lacking. Non-invasive breath analysis of volatile organic compounds (VOC) is a potential method for earlier LC detection. This study explores the association of VOC profiles with artificial intelligence (AI) to achieve a sensitive, specific, and fast method for LC detection. Patients and methods: Exhaled breath air samples were collected from 123 healthy individuals and 73 LC patients at two clinical sites. The enrolled patients had LC diagnosed with different stages. Breath samples were collected before undergoing any treatment, including surgery, and analyzed using gas chromatography coupled to ion-mobility spectrometry (GC-IMS). AI methods classified the overall chromatographic profiles. Results: GC-IMS is highly sensitive, yielding detailed chromatographic profiles. AI methods ranked the sets of exhaled breath profiles across both groups through training and validation steps, while qualitative information was deliberately not taking part nor influencing the results. The K-nearest neighbor (KNN) algorithm classified the groups with an accuracy of 90% (sensitivity = 87%, specificity = 92%). Narrowing the LC group to those only in early-stage IA, the accuracy was 90% (sensitivity = 90%, specificity = 93%). Conclusions: Evaluation of the global exhaled breath profiles using AI algorithms enabled LC detection and demonstrated that qualitative information may not be required, thus easing the frustration that many studies have experienced so far. The results show that this approach coupled with screening protocols may improve earlier detection of LC and hence its prognosis.
Funder
Champalimaud Foundation
Reference46 articles.
1. Ferlay, J., Ervik, M., Lam, F., Laversanne, M., Colombet, M., Mery, L., Piñeros, M., Znaor, A., Soerjomataram, I., and Bray, F. (2024, April 02). Global Cancer Observatory (GCO) Cancer Today. Available online: https://gco.iarc.who.int/media/globocan/factsheets/cancers/15-trachea-bronchus-and-lung-fact-sheet.pdf. 2. Stage Shift Improves Lung Cancer Survival: Real-World Evidence;Yang;J. Thorac. Oncol.,2022 3. Reduced Lung-Cancer Mortality with Volume CT Screening in a Randomized Trial;Scholten;N. Engl. J. Med.,2020 4. Global Patterns of Cancer Incidence and Mortality Rates and Trends;Jemal;Cancer Epidemiol. Biomark. Prev.,2010 5. Cancer statistics, 2020;Siegel;CA Cancer J. Clin.,2020
|
|